Leukemia-selective uptake and cytotoxicity of CPX-351, a synergistic fixed-ratio cytarabine:daunorubicin formulation, in bone marrow xenografts - Concepedia

Concepedia

Publication | Closed Access

Leukemia-selective uptake and cytotoxicity of CPX-351, a synergistic fixed-ratio cytarabine:daunorubicin formulation, in bone marrow xenografts

155

Citations

28

References

2010

Year

Wah-Seng Lim, Paul Tardi, Nancy Dos Santos, Xiaowei Xie, Mannie Fan, Barry D. Liboiron, Xiaoping Huang, Troy O. Harasym, David Bermudes, Lawrence D. Mayer

Leukemia Research

Hematological MalignancyLeukemia-selective UptakeMedicineHematologyBone Marrow XenograftsSynergistic Fixed-ratio CytarabinePharmacotherapyAnti-cancer AgentPharmacologyCell BiologyTumor BiologyMyeloid Neoplasia

References

	Year	Citations

Page 1

Page 1